SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EntreMed (ENMD)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
2135 59 0 ENMD
Emcee:  Mark Wise Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1885 BURLINGAME, Calif., April 6 /PRNewswire/ -- Megabios Corp. (Nasdaq: MBIO) (whicmuddphudd-4/6/1999
1884 Highly publicized cancer drug also shows promise against heart songw-4/5/1999
1883 "60 MINUTES" will feature cancer drug this sunday. cbs.comBedrock-4/3/1999
1882 Not Entremed, just for those interested in new therapies. msnbc.comTerry D.-4/2/1999
1881 I doubt human serum plasminogen is an adequate source for the reasons you mentiEPro-4/1/1999
1880 Green tea blocks cancer blood vessel growth - study abcnews.go.com <i>Ckinkblot-4/1/1999
1879 Thanks EPro. I noticed in the article that they used angiostatin made from humaNature Boy-3/31/1999
1878 Perhaps the Monday uptick was in response to news that SUGN is to be featured oEPro-3/30/1999
1877 Anybody know why the uptick before closing Monday? Nature BoyNature Boy-3/29/1999
1876 Tommy: Interesting. TedCage Rattler-3/26/1999
1875 Theodore : What I've heard is that phase III could START as soon as late fTommy Johnsen-3/26/1999
1874 Tommy: What is the source of the rumor alleging complete "cure" duriCage Rattler-3/25/1999
1873 Have any of you Entremed-holders (or shorters) taken a look at OXiGENE (OXGN) lTommy Johnsen-3/25/1999
1872 ACC, Sorry for not responding right away, I was 1000 miles from my PC scuba John Starks-3/23/1999
1871 Your characterization of how things stand now regarding those two drugs is wronJon Koplik-3/23/1999
1870 They outlicensed it to Celgene... Doorman-3/23/1999
1869 who is the someone? and what about the distaerous angio and endostatin compounAnthony@Pacific-3/23/1999
1868 They now get revenues on their deal with someone selling Thalidomide to treat cJon Koplik-3/23/1999
1867 Maybe you can tell me how they plan on making money any time within the next 10Anthony@Pacific-3/23/1999
1866 Maybe you should preface some of your posts with the word "advertisement.&Jon Koplik-3/23/1999
1865 Thank you for your concern. Just who might these insiders be? I see about 20%David Winkler-3/22/1999
1864 ENMD is still an overvalued issue that should be sold and discarded just as theAnthony@Pacific-3/22/1999
1863 Folkman does not work for enmd or genzyme, he works for Harvard Medical School David Winkler-3/21/1999
1862 Is Dr. M. Judan Folkman still working for enmd or has he gone over the GenzymKYA27-3/21/1999
1861 Hospitals selected for human ES testing jsonline.commarc ultra-3/20/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News